Skip to content
Review Open access

Hope for a cure: Exploratory analysis of prognostic awareness of people living with advanced lung cancer.

Oct 2026 · JCO Oncology Practice · 0 citations

Abstract

402 Background: Despite improved outcomes for stage IV lung cancer over the last decade, it remains the leading cause of cancer-related mortality. Discussions of prognosis and treatment decisions are complex and influenced by multiple factors. This study examines characteristics of patients with advanced lung cancer and their beliefs on curability. Methods: We analyzed data from Project PEER, a global online longitudinal survey of people with lung cancer. Participants who reported stage IV NSCLC or extensive-stage SCLC at the time of enrolment (n = 328) were included. Descriptive analysis examined socio-demographics, geography, time since diagnosis, comfort with doctor, severity of symptoms, and quality of life (QoL) juxtaposed to perceptions of the curability of their cancer, their primary goal of treatment, and their perceived primary goal of treatment of their oncologist. Perception of curability was measured with a Likert-type scale of the likelihood of being cured, with somewhat likely to extremely likely categorized as “curable prognostic perception” and a little likely to not at all likely as “not curable prognostic perception.” Results: Mean age of participants was 56 (range 29-81), most were female (77%) and completed undergraduate (30%) or postgraduate education (35%). Seventy-one percent of patients had a not curable prognostic perception while 22% had a curable prognostic perception. Seven percent indicated not knowing. Participants with curable prognostic perceptions tended to report no biomarker(s) (p <.05) and be male (p <.05). This group also tended to live outside of the U.S., have some secondary or completed secondary education, and have higher QoL, though differences were not significant. No relationship was found with comfort-level with doctor, time since diagnosis, or side effect severity. Most reported the primary goal of their treatment was to extend their life as long as possible (77%), with congruence with what they believed were their oncologist’s primary goals (82%). Of patients with curable prognostic perceptions, 24% believed the primary goal of their treatment was to cure their cancer while 48% believed it was to extend life as long as possible. Comparatively, those with not curable prognostic perceptions, results were less than 1% and 86%, respectively. Conclusions: Most participants reported prognostic awareness congruent with their advanced cancer diagnosis. Embedding goal-of-care discussions into routine oncology visits may improve alignment between perceived and actual treatment intent. However, conversations around prognostic outcomes must be approached with care to maintain hope and support QoL. Any interventions to improve prognostic awareness must emphasize communication in delivering nuanced prognostic information across diverse patient populations.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.